As described in the next section, these observations agree with a previous report supporting a prominent role for DYRK1A as a potent megakaryoblastic tumor-promoting gene that contributes to DS-associated AMKL leukemogenesis (Malinge et al., 2012). The gene discussed is DYRK1A; the disease is Dravet syndrome.